StocksAstraZenecaAZN.L

AZN.L

AstraZeneca

10710.35 211.81 (2.02%)
Prices By Xignite, in GBX Market Closed
Trade
S
10710.35
B
10733.65

Overview

Prev Close10710.35
Day's Range 10506.54 - 10728.34
52 Week Range 8027.77 - 11277.84
Average Volume (3m)1.68M
1-Year Return26.30%
Beta0.0662
Market Cap165.98B
P/E Ratio548.95
Revenue33.23B
EPS-0.5967
Dividend (Yield)2.217 (2.07%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.702/03/202216/05/202226/07/20228500.009000.009500.0010000.0010500.0011000.0011500.00
Chart times in UTC
Industry Pharmaceuticals Major
CEO Pascal Soriot, MBA, DVM
Employees 83,100

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: AstraZeneca's revenues increased by 30.13% and amounted to 28.00B. Net income decreased by 96.59% to 83.62M. Net assets increased by 153.55% to 29.01B and EPS decreased from 1.90 to 0.06.
AZN.L's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
56.69%
Net Profit Margin
8.09%
Operating Margin
4.19%
Return On Investment
6.45%
09/21
12/21
03/22
06/22
Total Revenue
7.16B
8.91B
8.49B
8.59B
Gross Profit
3.65B
4.59B
5.15B
5.38B
Operating Income
-72.58M
N/A
637.57M
526.97M
Net Income
-1.2B
-256.73M
289.33M
287M